HomePTGX • BMV
add
Protagonist Therapeutics Inc
Previous close
$1,495.51
Year range
$1,174.25 - $1,705.51
Market cap
5.88B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.44M | -95.64% |
Operating expense | 57.79M | 31.77% |
Net income | -44.38M | -133.71% |
Net profit margin | -596.80 | -873.36% |
Earnings per share | -0.69 | -134.85% |
EBITDA | -49.98M | -139.39% |
Effective tax rate | -1.52% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 567.36M | 35.44% |
Total assets | 668.19M | -10.28% |
Total liabilities | 53.48M | -22.97% |
Total equity | 614.71M | — |
Shares outstanding | 63.81M | — |
Price to book | 152.29 | — |
Return on assets | -18.38% | — |
Return on capital | -19.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -44.38M | -133.71% |
Cash from operations | -36.98M | -26.72% |
Cash from investing | 48.82M | 659.48% |
Cash from financing | 2.84M | -29.62% |
Net change in cash | 14.68M | 143.33% |
Free cash flow | -21.24M | 71.21% |
About
Founded
2006
Headquarters
Website
Employees
132
